March

Founding team of the company was formed.

Established in-depth cooperation with Soochow University and the Suzhou Institute of Nano-Tech and Nano-Bionics (SINANO), Chinese Academy of Sciences.

May

Suzhou Huiliao Biotechnology was established and settled in the 2.5 Industrial Park.

Secured angel round investment from institutions such as Sequoia Capital, Qipu Investment, and Huidin Investment.

Awarded the Suzhou Industrial Park Technology Leadership (Incubation) Project.

August

Reached in-depth cooperation with a leading vaccine enterprise.

Advanced the development of infectious disease vaccine and oncology therapeutic product pipelines.

November

Completed the construction of a 1,600-square-meter facility, including an 800-square-meter GMP pilot plant.

Established the Soochow University-Huiliao RNA Drug Collaborative Innovation Center.

Established the Soochow University Graduate Workstation.

April

Recognized as a National Technology-based Small and Medium-sized Enterprise.

May

Awarded the Jiangsu Province Quality Credit Grade A Enterprise.

June

Recognized as a Jiangsu Province Private Technology Enterprise.

September

Selected as one of the first batch of Gusu Innovation and Entrepreneurship Leading Talent Enterprises in 2022.

May

Designated as a unit for filing the implementation of enterprise intellectual property management in Jiangsu Province.

December

Honored as the Vice - Chairman Unit of the First Council of the Nucleic Acid Drug Branch of the China Veterinary Drug Association. 

Rated as a "unicorn" cultivation enterprise in Suzhou.